KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...

Prostate cancer is one of the most common cancers in men globally. Diagnosing prostate cancer involves examining tissue ...

President Trump said that Iran appeared to have rejected a key element of an American proposal aimed at breaking the deadlock ...

Jurors weighing Harvey Weinstein’s fate pleaded for a dose of caffeine as their grueling deliberations continued Monday — with yet another dramatic revelation about apparent ...

Getting a cortisone shot for knee arthritis might provide quick pain relief, but new research reveals a troubling association ...

Doctors and researchers are exploring various approaches to tackle this pervasive health issue, from new medications to dietary interventions. But what if one of the most promising treatments relies ...

More older people are using cannabis products regularly, but research suggests their cannabis-related health problems are ...

Merck & Co., Inc. (NYSE:MRK) on Monday shared topline results from the first two of three Phase 3 clinical trials evaluating ...

Ibogaine is illegal in the United States, but Texas is on the verge of spending up to $50 million to jumpstart clinical ...

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...